Accendra Health, Inc.ACHNYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank36
3Y CAGR-13.9%
5Y CAGR-6.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-13.9%/yr
Annual compound
5Y CAGR
-6.2%/yr
Recent deceleration
Percentile
P36
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$235.23M+359.2%
2024$51.22M-86.9%
2023$390.57M+6.0%
2022$368.45M-11.3%
2021$415.46M+28.5%
2020$323.41M+73.2%
2019$186.72M+168.5%
2018$-272.71M-230.2%
2017$209.40M-25.1%
2016$279.67M-